Abstract
In this chapter, intraluminal brachytherapy (ILBT) for biliary tract cancer is discussed. Because of its rarity and poor prognosis and generally it is difficult to cover whole tumor with intraluminal brachytherapy, there exists no prospective study showing survival benefit of ILBT for biliary tract cancer. However, large retrospective study showed effectiveness of ILBT in local control for unresectable biliary tract cancer patients. Local control of the disease holds great significance for such patients; therefore, ILBT could be considered when applicable.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cancer Registry and Statistics. Cancer Information Service, National Cancer Center, Japan.
Anderson CD, Pinson CW, Berlin J, et al. Diagnosis and treatment of cholangiocarcinoma. Oncologist. 2004;9:43–57.
Ikeda K, Kuroda C, Uchida H, et al. Intraluminal irradiation with Ir-192 wires for extrahepatic bile duct carcinoma. Nihon Igaku Houshasen Gakkai Zasshi. 1979;39:1356–8.
Koster R, Schmidt H, Greuel H, et al. Bestrahlung von malignen Gallengangsverschlüssen in Afterloading-Technik. Strahlentherapie. 1982;158:678–80.
Itami J, Saegusa Y, Tsuchiya T, et al. Intrakavitaere high-dose-rate-afterloading-Bestrahlung beim inoperablen malignen Gallengangsverschluss. Strahlenther Onkol. 1986;162:105–10.
Montemaggi O, Costamagna G, Dobelbower R, et al. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1995;32:437–43.
Kamada T, Saitou H, Takamura A, et al. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys. 1996;34:767–74.
Gonzalez D, Gouma D, Rauws E, et al. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma. Ann Oncol. 1999;10:215–20.
Yoshioka Y, Ogawa K, Oikawa H, et al. Impact of intraluminal brachytherapy on survival outcome for radiation therapy for unresectable biliary tract cancer: a propensity score matched-pair analysis. Int J Radiation Oncol Biol Phys. 2014;89(4):822e829.
Mattiucci GC, Autorino R, Tringali A, et al. A phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer. Brachytherapy. 2015;14:401–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Murakami, N., Itami, J. (2019). Intraluminal Brachytherapy for Biliary Tract Cancer. In: Yoshioka, Y., Itami, J., Oguchi, M., Nakano, T. (eds) Brachytherapy. Springer, Singapore. https://doi.org/10.1007/978-981-13-0490-3_22
Download citation
DOI: https://doi.org/10.1007/978-981-13-0490-3_22
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-0489-7
Online ISBN: 978-981-13-0490-3
eBook Packages: MedicineMedicine (R0)